Table of contents
December 2008 - Volume 67 - Suppl 3
Advances in targeted therapies X
Preface
- Advances in targeted therapies X (20 November, 2008)
Consensus statement
Tolerance and inflammation
- Th17 cells in immunity and autoimmunity (20 November, 2008)
Clinical outcomes assessment
- Why do people with rheumatoid arthritis still die prematurely? (20 November, 2008)
New cell and cytokine targets ii
- Stem cell transplantation: a treatment option for severe systemic sclerosis? (20 November, 2008)
- Alloreactive natural killer cells in targeting high-risk leukaemias (20 November, 2008)
- Interleukin 21 as a target of intervention in autoimmune disease (20 November, 2008)
- How to cope with pathogenic long-lived plasma cells in autoimmune diseases (20 November, 2008)
- Tolerogenic dendritic cells for autoimmune disease and transplantation (20 November, 2008)
Innate immunity and autoimmunity
- Adding fuel to fire: microRNAs as a new class of mediators of inflammation (20 November, 2008)
- Lessons from multiple sclerosis: models, concepts, observations (20 November, 2008)
Translational medicine: brief reports
- Protection against rheumatoid arthritis by HLA: nature and nurture (20 November, 2008)
Osteoarthritis
Biological and clinical markers
- Epigenetic mechanisms in health and disease (20 November, 2008)